Although we have shown that ALDOC can promote the progression of NB by increasing the rate of glycolysis in NB cells and inhibiting the degradation of MYCN, stabilizing its oncogenic function and accelerating the malignant progression of NB, our research findings are based on cellular-level studies. The gene discussed is ALDOC; the disease is neuroblastoma.